NDC 69097-261
SOLIFENACINE SUCCINATE
Solifenacine Succinate
SOLIFENACINE SUCCINATE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Solifenacin Succinate.
| Product ID | 69097-261_13de71d6-5be1-49ee-b2cf-e3d7c8fd7b45 |
| NDC | 69097-261 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SOLIFENACINE SUCCINATE |
| Generic Name | Solifenacine Succinate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-05-20 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209839 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | SOLIFENACIN SUCCINATE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |